Analiza ekspresji wolnych mikroRNA we krwi u pacjentów z pierwszym atakiem padaczki i nowo rozpoznaną epilepsją
Exploratory analysis of cell-free miRNA expression changes in patients with isolated first seizure and new-onset epilepsy
W skrócie
Badacze badali małe cząsteczki RNA we krwi (mikroRNA) u 20 pacjentów, którzy mieli pierwszy atak padaczki. Po obserwacji przez 2 lata okazało się, że 7 pacjentów miało kolejny atak, a u pozostałych go nie było. Naukowcy znaleźli 15 różnych mikroRNA, które mogą wskazywać, czy pacjent ma wysokie ryzyko kolejnego ataku i rozwoju epilepsji, co może w przyszłości pomóc w szybkim rozpoznaniu choroby i uniknięciu niepotrzebnego leczenia.
Oryginalny abstract (angielski)
One in ten individuals will experience a seizure in their lives, but only 43%-61% will be diagnosed with new-onset epilepsy (NOE). Existing methods to distinguish between a first unprovoked seizure and a diagnosis of epilepsy are inadequate and often lead to unnecessary treatment with antiseizure medications. To uncover potential targets associated with NOE, we analyzed cell-free circulating miRNA expression in plasma samples obtained from 20 patients who presented with a first unprovoked seizure. Patients were monitored for 2 years following their initial seizure, and a total of 7 patients experienced a second seizure within the follow-up period. Analysis of the miRNA expression levels revealed 15 differentially expressed miRNAs between patients who experienced only a first unprovoked seizure versus those who had a second seizure. These 15 miRNAs were experimentally linked as regulators to 160 genes related to epilepsy, including genes involved in the mTOR and WNT signaling pathways. These findings highlight a number of key circulating miRNA targets that may be further developed as a biomarker signature in larger cohorts and may offer insights into factors associated with epileptogenesis.